SUBSCRIBE
SUBSCRIBE

Radionetics

NEWS
Eli Lilly's biotechnology center in California
Deals
Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech
Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right to acquire the biotech for $1 billion.
July 2, 2024
 · 
2 min read
 · 
Tristan Manalac
Business
Movers & Shakers: Lyell Immunopharma, Radionetics Oncology, AlivaMab Discovery and More
Life science companies made adjustments to their leadership teams with multiple appointments for chief commercial officers, chief business officers and more in this week’s Movers & Shakers.
September 29, 2022
 · 
4 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Radionetics Oncology Enters Into Strategic Agreement With Lilly
July 1, 2024
 · 
2 min read
Biotech Beach
GordonMD® Announces Second Investment in Radiopharmaceutical Biotech Radionetics Oncology
January 5, 2024
 · 
1 min read
Business
Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader, Paul Grayson, as CEO
January 3, 2024
 · 
3 min read
Drug Development
Radionetics Oncology Announces Initiation of Phase 1 Radiopharmaceutical Program Against a Novel Target for Adrenocortical Carcinoma
October 17, 2023
 · 
3 min read
Business
Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
February 22, 2023
 · 
4 min read
Business
Radionetics Oncology Appoints Umesh Gangadharmath, Ph.D. as Senior Vice President, Technical Operations
September 27, 2022
 · 
4 min read
Business
Radionetics Oncology Appoints Nishan de Silva, M.D. as Chief Executive Officer
April 12, 2022
 · 
5 min read
Business
Radionetics Oncology Emerges from Crinetics Pharmaceuticals with a Platform and Deep Pipeline of Nonpeptide Targeted Radiopharmaceutical Drug Candidates for Precision Oncology
October 18, 2021
 · 
11 min read